IGC-1A

N/A

Report date: 2026/04/07 20:00:20

NME

Base Information

Drug NameIGC-1A

Drug Alias NameIGC-1A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsCannabinoid CB1 receptor inverse agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonists

TargetsGlucagon-like peptide 1 receptorCannabinoid CB1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor

Therapy Area/IndicationsMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIGC Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesIGC Pharma Inc

Inactive CompaniesN/A

Active IndicationsMetabolic Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A